Ezziddin, Samer; Sabet, Amir; Heinemann, Florian; Yong-Hing, Charlotte J; Ahmadzadehfar, Hojjat; Guhlke, Stefan; Höller, Tobias; Willinek, Winfried; Boy, Christian; Biersack, Hans-Jürgen (2011). Response and long-term control of bone metastases after peptide receptor radionuclide therapy with (177)Lu-octreotate. Journal of nuclear medicine, 52(8), pp. 1197-203. New York, N.Y.: Society of Nuclear Medicine 10.2967/jnumed.111.090373
Full text not available from this repository. (Request a copy)Peptide receptor radionuclide therapy (PRRT) is an efficient treatment for gastroenteropancreatic neuroendocrine tumors (GEP NETs), with outstanding overall response rates and survival. However, little is known about the particular efficacy regarding bone metastasis (BM).
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine |
UniBE Contributor: |
Boy, Christian |
ISSN: |
0161-5505 |
Publisher: |
Society of Nuclear Medicine |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:19 |
Last Modified: |
05 Dec 2022 14:05 |
Publisher DOI: |
10.2967/jnumed.111.090373 |
PubMed ID: |
21764798 |
Web of Science ID: |
000293336000033 |
URI: |
https://boris.unibe.ch/id/eprint/6165 (FactScience: 211067) |
Actions (login required)
 |
Edit item |